Millennium Management
NTRP

Millennium Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Millennium Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,399
Closed -$28K – 4826
2019
Q3 		$28K Buy
+35,399
New +$162K ﹤0.01% 4077
2018
Q4 		– Sell
-14,928
Closed -$132K – 4383
2018
Q3 		$132K Buy
+14,928
New +$143K ﹤0.01% 3709

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management's NTRP Position: Q4 2019 in Review

Millennium Management sold out of Neurotrope, Inc. Common (NTRP) in Q4 2019, closing a stake of 35,399 shares — an estimated $28K sold.

Millennium Management first reported a position in NTRP in Q3 2018 and held it in 2 quarters. The position peaked at $132K in Q3 2018. 21 funds tracked by Wall St. Rank hold NTRP as of Q4 2019.

  • Millennium Management reported no remaining Neurotrope, Inc. Common position as of Q4 2019 after selling out during the quarter.
  • Millennium Management sold 35,399 Neurotrope, Inc. Common shares in Q4 2019, an estimated $28K.
  • Millennium Management first reported a position in Neurotrope, Inc. Common in Q3 2018 and held it in 2 quarters.
  • Millennium Management's Neurotrope, Inc. Common position peaked at $132K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.